Answers are grounded in this paper and cite their sources.
Tight blood glucose control is a primary aim of type 2 diabetes treatment. Combining metformin with the amino acid derivative, nateglinide, tackles both beta cell dysfunction and insulin resistance, and produces a greater decrease in haemoglobin A1c levels than treatment with either drug alone.
No takes yet. Share an insight, caveat, or question.
J. W. Andrews (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: